Novotech Recognized with Workplace Gender Equality Award

Sydney - Australia – Novotech, the largest biotech specialist CRO in the Asia-Pacific, has been recognized by the Workplace Gender Equality Agency (WGEA) as a WGEA Employer of Choice for Gender Equality (EOCGE).... more

Wednesday, February 26th, 2020 - Novotech CRO

Independent Plexaris and Cevaris testing shows positive and unique results

Exopharm is a world leader in the manufacture of exosome products.... more

Wednesday, February 12th, 2020 - Exopharm

Novotech Wins Australian-Korean Business Excellence Award 2020

Seoul, South Korea - Asia-Pacific specialist CRO Novotech has won the Australian-Korean Business Awards 2020 - Award for Excellence, in the category Biotech and Health.... more

Wednesday, February 5th, 2020 - Novotech CRO

These ASX Performers (ASX:KNL)(ASX:NHL)(ASX:CSV) Rally On Huge Volume

Sector Reports is please to provide coverage of some of todays ASX top performers and offer access to our complimentary research reports. Simply follow this link for instant access https://www.sectorreports.com.au/landing-page... more

Friday, October 25th, 2019 - Sector Reports

Plexoval Exosome Wound Healing Human Study Starts

An important step forward for Exopharm: A clinical-stage company and world leader in exosome therapeutics for regenerative medicine.... more

Monday, August 26th, 2019 - Exopharm

Clinical stage Exopharm announces a successful Placement and the opening of a Share Purchase Plan

Melbourne, Australia: Exopharm Limited (ASX:EX1) has finalised a A$4.44 million share placement to new institutional and sophisticated investors.  A further Share Purchase Plan (SPP) to existing shareholders has a target raise of A$2.7m.... more

Friday, July 26th, 2019 - Exopharm

Exopharm Secures Ethics Approval for the Plexoval Clinical Trial

Melbourne, Australia: Exopharm Limited (ASX:EX1) has received approval from Melbourne Health Human Research Ethics Committee to commence the PLEXOVAL wound healing study with its PlexarisTM product under the Australian Clinical Trials Notification (C... more

Monday, July 22nd, 2019 - Exopharm

The Next Big Thing in Regenerative Medicine: Exosomes

Stem cell therapy once seemed beguilingly simple. It was thought that by injecting additional stem cells into the body, the new cells would transform the way that we treat certain conditions. But nearly 20 years on, the general safety and efficacy of... more

Thursday, July 18th, 2019 - Exopharm

If you have concerns about skin cancer you must read this

Most skin cancers are a locally destructive cancerous growth of the skin. They originate from the cells of the outer layers of the skin (the epidermis) and unlike malignant melanoma, the vast majority of these sorts of skin cancers rarely s... more

Monday, July 15th, 2019 - Global Health Direct Pty Ltd

Australian Research leads to global solution for treatment of Actinic Keratosis (AK Sunspots)

Actinic Keratosis (AK) is that scaly, red, and occasionally itchy patch of skin, resembling a mole, that usually appears on patients over 50 years old, but can manifest in younger adults particularly with prolonged sun exposure. The percentage risk o... more

Tuesday, April 9th, 2019 - Global Health Direct Pty Ltd